From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry.
|Videos|July 28, 2019
OD text groups keep the conversation going
Author(s)Scott Schachter, OD
Advertisement
Scott Schachter, OD, shares why he created a text group of eyecare professionals specializing in ocular surface disease, and how the group has proven to be a resource for stimulating conversation and ideas.
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MultiMedia Healthcare LLC.
Advertisement
Related to this article
Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
2
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
3
Missed AAOpt 2026? Here are the highlights by specialty
4
FDA approves subcutaneous Enspryng for TED
5